Goodbody Health Stock Canadian Securities Exchange
Equities
SWEL
CA3821591011
Pharmaceuticals
Sales 2020 | 1.99M 2.47M 3.39M | Sales 2021 | 17.06M 21.1M 29.02M | Capitalization | 13.76M 17.02M 23.4M |
---|---|---|---|---|---|
Net income 2020 | -4M -4.95M -6.8M | Net income 2021 | -2M -2.47M -3.4M | EV / Sales 2020 | 5.41 x |
Net cash position 2020 | 1.37M 1.7M 2.34M | Net cash position 2021 | 5.73M 7.09M 9.75M | EV / Sales 2021 | 0.47 x |
P/E ratio 2020 |
-1.4
x | P/E ratio 2021 |
-5.64
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 70.26% |
Managers | Title | Age | Since |
---|---|---|---|
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
John Pettit
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Geremy Thomas
FOU | Founder | 64 | 11-02-13 |
George Thomas
CEO | Chief Executive Officer | 35 | 21-01-25 |
Anne Tew
SEC | Corporate Secretary | - | 18-10-31 |
1st Jan change | Capi. | |
---|---|---|
+40.86% | 6.16B | |
-16.30% | 4.49B | |
-9.93% | 3.17B | |
-1.58% | 3.01B | |
-1.70% | 2.57B | |
+37.23% | 1.8B | |
-12.78% | 1.62B | |
+1.02% | 1.56B | |
-12.97% | 1.53B |